Mirae Asset Global Investments’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,359
Closed -$2.79M 2647
2022
Q3
$2.79M Sell
11,359
-524
-4% -$142K 0.01% 1010
2022
Q2
$2.94M Buy
+11,883
New +$3.21M 0.01% 1010
2021
Q4
Sell
-7,062
Closed -$2.3M 1801
2021
Q3
$2.3M Buy
7,062
+1,152
+19% +$390K 0.01% 1079
2021
Q2
$1.84M Buy
5,910
+627
+12% +$192K 0.01% 1088
2021
Q1
$1.68M Buy
5,283
+566
+12% +$181K 0.01% 992
2020
Q4
$1.53M Buy
4,717
+934
+25% +$258K 0.01% 1015
2020
Q3
$1.05M Buy
3,783
+836
+28% +$241K 0.01% 952
2020
Q2
$712K Buy
2,947
+229
+8% +$46K ﹤0.01% 1017
2020
Q1
$394K Sell
2,718
-10,659
-80% -$1.77M ﹤0.01% 1100
2019
Q4
$2.28M Buy
13,377
+4,854
+57% +$900K 0.01% 718
2019
Q3
$1.52M Buy
8,523
+2,408
+39% +$521K 0.01% 784
2019
Q2
$1.59M Buy
6,115
+1,169
+24% +$310K 0.01% 778
2019
Q1
$1.41M Buy
4,946
+277
+6% +$92.1K 0.01% 728
2018
Q4
$1.52M Sell
4,669
-95
-2% -$33K 0.01% 669
2018
Q3
$2.14M Sell
4,764
-1,197
-20% -$472K 0.02% 640
2018
Q2
$2.44M Sell
5,961
-765
-11% -$277K 0.03% 323
2018
Q1
$1.96M Sell
6,726
-3,724
-36% -$944K 0.03% 378
2017
Q4
$1.96M Buy
+10,450
New +$1.95M 0.03% 353

Other funds holding ABMD

Mirae Asset Global Investments's ABMD Position: Q4 2022 in Review

Mirae Asset Global Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 11,359 shares — an estimated $2.79M sold.

Mirae Asset Global Investments first reported a position in ABMD in Q4 2017 and held it in 18 quarters. The position peaked at $2.94M in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Mirae Asset Global Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 11,359 Abiomed Inc shares in Q4 2022, an estimated $2.79M.
  • Mirae Asset Global Investments first reported a position in Abiomed Inc in Q4 2017 and held it in 18 quarters.
  • Mirae Asset Global Investments's Abiomed Inc position peaked at $2.94M in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Mirae Asset Global Investments's 13F filing for Q4 2022, filed 9 Feb 2023.